CR20190527A - Parche que contiene rupatadina - Google Patents
Parche que contiene rupatadinaInfo
- Publication number
- CR20190527A CR20190527A CR20190527A CR20190527A CR20190527A CR 20190527 A CR20190527 A CR 20190527A CR 20190527 A CR20190527 A CR 20190527A CR 20190527 A CR20190527 A CR 20190527A CR 20190527 A CR20190527 A CR 20190527A
- Authority
- CR
- Costa Rica
- Prior art keywords
- rupatadine
- external patch
- adhesive
- acrylic adhesive
- patch containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Adhesives Or Adhesive Processes (AREA)
Abstract
Se proporciona un parche externo que contiene rupatadina como antihistamina de segunda generación, tiene excelentes propiedades físicas de esparadrapo, buena adhesión cuando se aplica a la piel, y buena absorción transdérmica de rupatadina como principio activo. El parche externo que contiene rupatadina usa un adhesivo acrílico como base adhesiva. Específicamente, el parche externo que contiene rupatadina usa un adhesivo acrílico como base adhesiva y además contiene un ácido orgánico que tiene de 2 a 7 átomos de carbono como agente de solubilidad, un éster de ácido graso como agente de reblandecimiento y/o un tensioactivo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017082559 | 2017-04-19 | ||
PCT/JP2018/016692 WO2018194183A1 (en) | 2017-04-19 | 2018-04-18 | Rupatadine-containing patch |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20190527A true CR20190527A (es) | 2020-03-17 |
Family
ID=63856668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20190527A CR20190527A (es) | 2017-04-19 | 2018-04-18 | Parche que contiene rupatadina |
Country Status (15)
Country | Link |
---|---|
US (1) | US11179346B2 (es) |
EP (1) | EP3612182B1 (es) |
JP (1) | JP7228527B2 (es) |
KR (1) | KR102586423B1 (es) |
CN (1) | CN110740730B (es) |
BR (1) | BR112019021807A2 (es) |
CA (1) | CA3059682A1 (es) |
CR (1) | CR20190527A (es) |
DO (1) | DOP2019000270A (es) |
ES (1) | ES2971461T3 (es) |
FI (1) | FI3612182T3 (es) |
NI (1) | NI201900109A (es) |
PL (1) | PL3612182T3 (es) |
TW (1) | TWI825013B (es) |
WO (1) | WO2018194183A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4238563A1 (en) * | 2020-10-29 | 2023-09-06 | Hisamitsu Pharmaceutical Co., Inc. | Ropinirole-containing patch and method for improving skin permeability of ropinirole |
CN112494429B (zh) * | 2020-12-29 | 2022-07-26 | 北京华氏开元医药科技有限公司 | 一种富马酸卢帕他定纳米乳液及其制备方法与应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2042421B1 (es) | 1992-05-22 | 1994-08-01 | Uriach & Cia Sa J | Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina. |
US9259397B2 (en) * | 2000-10-23 | 2016-02-16 | Purdue Pharma L.P. | Loratadine transdermal device and methods |
DE10060852A1 (de) * | 2000-12-06 | 2002-06-20 | Hexal Ag | Absorptionsmittel und Kanalbildner enthaltende wirkstoffundurchlässige Deckschicht oder abziehbare Schutzschicht eines transdermalen therapeutischen Systems |
CN100411692C (zh) * | 2004-01-13 | 2008-08-20 | 北京康倍得医药技术开发有限公司 | 丙烯酸基粘合剂组合物及其药物组合物和透皮治疗系统 |
WO2007007863A1 (en) * | 2005-07-08 | 2007-01-18 | Senju Pharmaceutical Co., Ltd. | Percutaneously absorptive ophthalmic preparation comprising olopatadine |
EP2008651A1 (en) | 2007-06-26 | 2008-12-31 | Drug Delivery Solutions Limited | A bioerodible patch |
CN101933914A (zh) * | 2009-06-29 | 2011-01-05 | 杭州赛利药物研究所有限公司 | 地氯雷他定贴剂及其制备方法 |
JP5837276B2 (ja) * | 2009-09-30 | 2015-12-24 | 味の素株式会社 | 経口摂取用ゲル状組成物、及びその製造方法 |
CN102958926B (zh) | 2010-06-30 | 2014-04-23 | J·乌里亚奇·Y股份有限公司 | 抗组胺剂 |
US9566306B2 (en) * | 2012-04-16 | 2017-02-14 | Zemtsov Enterprises, Llc | Formulations and methods for treatment of wounds and inflammatory skin conditions |
-
2018
- 2018-04-17 TW TW107113055A patent/TWI825013B/zh active
- 2018-04-18 EP EP18788008.3A patent/EP3612182B1/en active Active
- 2018-04-18 FI FIEP18788008.3T patent/FI3612182T3/fi active
- 2018-04-18 PL PL18788008.3T patent/PL3612182T3/pl unknown
- 2018-04-18 US US16/605,237 patent/US11179346B2/en active Active
- 2018-04-18 CR CR20190527A patent/CR20190527A/es unknown
- 2018-04-18 CN CN201880025949.3A patent/CN110740730B/zh active Active
- 2018-04-18 JP JP2019557502A patent/JP7228527B2/ja active Active
- 2018-04-18 WO PCT/JP2018/016692 patent/WO2018194183A1/en active Application Filing
- 2018-04-18 CA CA3059682A patent/CA3059682A1/en active Pending
- 2018-04-18 KR KR1020197033995A patent/KR102586423B1/ko active IP Right Grant
- 2018-04-18 ES ES18788008T patent/ES2971461T3/es active Active
- 2018-04-18 BR BR112019021807A patent/BR112019021807A2/pt unknown
-
2019
- 2019-10-18 DO DO2019000270A patent/DOP2019000270A/es unknown
- 2019-10-18 NI NI201900109A patent/NI201900109A/es unknown
Also Published As
Publication number | Publication date |
---|---|
RU2019136691A3 (es) | 2021-07-13 |
EP3612182A1 (en) | 2020-02-26 |
EP3612182A4 (en) | 2020-09-16 |
CN110740730A (zh) | 2020-01-31 |
US20200121612A1 (en) | 2020-04-23 |
KR20200006065A (ko) | 2020-01-17 |
BR112019021807A2 (pt) | 2020-05-05 |
FI3612182T3 (fi) | 2024-02-19 |
JP7228527B2 (ja) | 2023-02-24 |
EP3612182B1 (en) | 2024-01-10 |
NI201900109A (es) | 2020-01-07 |
TWI825013B (zh) | 2023-12-11 |
KR102586423B1 (ko) | 2023-10-11 |
ES2971461T3 (es) | 2024-06-05 |
CA3059682A1 (en) | 2018-10-25 |
JP2020524657A (ja) | 2020-08-20 |
CN110740730B (zh) | 2024-01-09 |
RU2019136691A (ru) | 2021-05-17 |
TW201841638A (zh) | 2018-12-01 |
PL3612182T3 (pl) | 2024-05-13 |
DOP2019000270A (es) | 2019-12-30 |
US11179346B2 (en) | 2021-11-23 |
WO2018194183A1 (en) | 2018-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2017000102A (es) | Calzado que tiene estructuras augeticas con propiedades controladas. | |
MX2016007075A (es) | Formulacion adhesiva y metodos de plisado utilizando la misma. | |
DOP2016000339A (es) | Compuestos de heteroarilo útiles como inhibidores de enzima activadora de sumo | |
GB2550301A (en) | Antimicrobial fibers and compositions | |
PE20151778A1 (es) | Formulacion combinada de dos compuestos antivirales | |
BR112016025331A2 (pt) | composições antimicrobianas | |
MX2017009144A (es) | Dimeros de benzodiazepina unidos con puentes de heteroarileno, conjugados de estos, y sus metodos de preparacion y uso. | |
MX366560B (es) | Parche adhesivo con composicion antimicrobiana. | |
CL2018000070A1 (es) | Modulares de diaciglicerol aciltransderasa 2 (dgta2) | |
MX2014011710A (es) | Composiciones antimicrobianas ambientalmente preferidas. | |
AR084032A1 (es) | Compuesto biciclico | |
EA201290928A1 (ru) | Содержащая протеогликан совокупность микроигл | |
PE20150024A1 (es) | Compuestos que inhiben la actividad de catecol o-metiltransferasa | |
MX2018009277A (es) | Articulo absorbente con elemento de proteccion trasero plano. | |
MY181540A (en) | Transdermal composition containing donepezil as active ingredient | |
MX2019013561A (es) | Compuestos de pirrolopiridina-anilina para el tratamiento de trastornos dermicos. | |
NZ611920A (en) | Percutaneous absorption preparation containing rivastigmine | |
GEP20196969B (en) | New therapeutical composition containing apomorphine as active ingredient | |
BR112017013255A2 (pt) | emplastro em gel | |
CR20190527A (es) | Parche que contiene rupatadina | |
PE20170898A1 (es) | Inhibidor de cinasa aurora a | |
BR112012015084A2 (pt) | composição farmacêutica de liberação lenta de iloperidone | |
BR112014011066A2 (pt) | artigo absorvente com elemento de estabilização | |
AU2016204294A1 (en) | Solid State Forms Of A Quinazoline Derivative And Its Use As A BRAF Inhibitor | |
PE20141035A1 (es) | Composiciones y metodos para tratar el cancer usando el inhibidor de pi3kbeta y el inhibidor de la via de mapk, incluidos los inhibidores de mek y raf |